Compounds > angiotensin ii, des-phe(8)-
Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Critical Illness

angiotensin ii, des-phe(8)- has been researched along with Critical Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arslan, B; Ergun, NU; Kalkan, A; Kocatas, A; Onal, H; Semerci, SY; Suner, N; Topuz, S; Topuzogullari, M; Ugurel, OM; Yoldemir, SA1
Bitker, L; Burrell, LM1

Reviews

1 review(s) available for angiotensin ii, des-phe(8)- and Critical Illness

ArticleYear
Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill.
    Critical care clinics, 2019, Volume: 35, Issue:2

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiotensin I; Angiotensin II; Blood Pressure; Critical Illness; Female; Homeostasis; Humans; Male; Middle Aged; Peptide Fragments; Renin-Angiotensin System; Respiratory Distress Syndrome; Shock, Septic; Vasoconstrictor Agents

2019

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and Critical Illness

ArticleYear
Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2022, Volume: 61, Issue:4

    Topics: Adult; Aged, 80 and over; Angiotensin I; Blood Component Transfusion; COVID-19; Critical Illness; Female; Humans; Male; Oxygen; Peptide Fragments; Plasma; SARS-CoV-2; Treatment Outcome

2022